Rutherford to delist from AQSE Growth Exchange

The Rutherford Cancer Centre North East

Cancer care specialist Rutherford Health has announced its withdrawal from the AQSE Growth Market after shareholders backed the proposal at a general meeting this week. The company, which listed on the Growth Exchange then known as the NEX in February 2019, said the regulatory burden, management time and ‘considerable costs’ associated with maintaining admission to trading…

You must be a HM Subscriber to view this content.

Subscribe Now »